Objective: Most patients with cardiovascular disease continue to receive both aspirin and an angiotensin-converting enzyme (ACE) inhibitor. This is despite the fact that ACE inhibition also inhibits the enzyme kininase II and leads to accumulation of bradykinin which increases prostaglandins. We hypothesized that in normal veins, vasodilator prostaglandins contribute significantly to ACE inhibitor dilation of norepinephrine-induced venoconstriction, and this would be blocked by cyclooxygenase inhibition. Methods: The study was performed using the in vivo dorsal hand vein technique for measuring vascular responses directly. Venoconstriction to norepinephrine infusions (0.5-1024 ng / min) was assessed in eight normal subjects (4665 years, mean6S.E.M.) during coinfusion of saline in one hand (control) and enalaprilat (1000 mg / min) in the contralateral hand. On a second morning (761 days apart, mean6S.E.M., random order), the same procedure was repeated with indomethacin (3 mg / min) coinfusion in both hands. Results: Enalaprilat shifted the norepinephrine dose-response curve to the right (P50.024) and increased the norepinephrine log ED (dose required to cause 50% venoconstriction) 50 from 1.7060.08 to 2.3160.11 log ng / min (P50.001). Indomethacin shifted the norepinephrine dose-response curve to the left (P50.018) and decreased the norepinephrine log ED from 1.7060.08 to 1.0960.18 log ng / min (P50.002). In the presence of 50 indomethacin, enalaprilat caused only a small but significant increase in the norepinephrine log ED , from 1.0960.18 to 1.2960.18 log 50 ng / min (P50.041). Conclusions: The results suggest that vasodilator prostaglandins contribute significantly to the attenuation of sympathetic venoconstriction by enalaprilat. This may have clinical relevance in patients receiving aspirin and ACE inhibitors in the setting of increased sympathetic activity.
are well known and the benefits of ACE inhibitors in Subjects refrained from drinking alcohol or caffeine-conreducing sympathetic responses may be mediated by their taining beverages for at least 12 h prior to the study. inhibitory effects on angiotensin II synthesis [7] . While the main benefit of ACE inhibitors is accepted as being 2 .2. Experimental protocol through a reduction in angiotensin II levels, it has been proposed that a contribution also occurs from inhibition of
The study was performed on two mornings (761 days endothelial ACE / kininase II, leading to accumulation of apart) in a quiet, temperature-controlled environment (22-bradykinin, a potent endogenous vasodilator with effects 24 8C). Subjects were allowed to rest for 30 min before mediated by factors which include prostacyclin and nitric starting the study during which time, if their lipid profile oxide [8, 9] . However, little is known about ACE inhibitor was not known, blood samples were collected for subattenuation of sympathetic vasoconstriction at the postsequent analysis. With the subject lying in the supine synaptic vascular level. The ability of enalaprilat to position, two 27-gauge butterfly needles (E-Z Set, Becton mediate local dilation of preconstricted dorsal hand veins Dickinson, Sandy, UT, USA) were inserted in each hand was demonstrated previously [10] and two other studies into the straight portion of a dorsal hand vein with no reported that ACE inhibitors attenuated vascular responses immediate tributaries and continuous saline infusions (0.2 to sympathetic stimulation [7, 11] but the mechanisms ml / min through each needle) were started using infusion involved, including the role of prostaglandins, were not pumps (Harvard, model 2400-003, South Natick, MA, investigated. By facilitating accumulation of bradykinin USA). [8, 9] , ACE inhibitors would be expected to have favorable Distension of dorsal hand veins was measured using the effects on prostaglandin synthesis in veins where nitric linear variable differential transformer technique [15] as oxide responses are reduced compared to arteries [12, 13] previously described [16] . This technique has been evaluand this may mean an increased role for prostaglandins.
ated and found to be highly reproducible as a means of Hence further studies are necessary to assess directly the studying venous responses repeatedly within subjects role of prostaglandins in modulating vasoconstriction [15, 17] . A sphygmomanometer cuff was placed on each during ACE inhibition in order to further understand upper arm and a mechanical cuff inflater (Hokanson, general hemodynamic effects which have been reported. model G101, Winston-Salem, NC, USA) was used to The aim of this study therefore was to determine the intermittently inflate and maintain cuff pressure at 45 influence of ACE inhibition on venoconstriction to NE, mmHg at which vein distension was measured. Both lower focusing in particular on the modulatory role of vasodilator arms were rested on padded supports elevated to 308 from prostaglandins. The study was designed to test the hypoththe horizontal to allow for emptying of hand veins during esis that vasodilator prostaglandins contribute significantly cuff deflation. The transducers of the linear variable to ACE inhibitor dilation of NE-induced venoconstriction differential transformers (Type 025 MHR, Schaevitz Enand this would be blocked by cyclooxygenase inhibition.
gineering, Pennsauken, NJ, USA), housed in lightweight tripod stands, were placed over the veins with the central movable cores resting on the summit of the veins approximately 10 mm downstream from the tips of the most 2 . Methods proximal needles and their positions were recorded continuously on chart recorders. Measurements of vein disten-2 .1. Subjects sion were made by inflating both cuffs for 2 min, during which stable plateau peaks were recorded, followed by This investigation conforms with the principles outlined deflation for 3 min. This was repeated until stable baseline in the Declaration of Helsinki [14] . All subjects gave measurements of vein distension had been recorded (at written informed consent to the study protocol approved by least two consistent peaks). the University of Western Ontario's review board for On one of the study days (randomly assigned), after health sciences research involving human subjects. A total obtaining stable baseline measurements of vein distension, of 14 volunteers participated in the study but five were the saline syringe for one of the distal needles (randomly excluded because they were found to be hypercholesselected) was replaced by an infusion of enalaprilat (1000  terolemic upon analysis of blood samples while one ng / min; Vasotec , Merck Frosst, Kirkland, Quebec, subject was excluded for having incomplete results. The Canada) which was maintained for the rest of the duration results are of eight normal subjects, four females and four of the study. Fifteen minutes after the start of the the males (age 4665 years, mean6S.E.M.; weight 6565 kg).
enalaprilat infusion, graded doses of norepinephrine (NE; The subjects were normotensive, non-smokers, not taking 0.5-1024 ng / min; Sabex, Boucherville, Quebec, Canada) any medications and in general good health according to were then infused through each proximal needle for 5 min history, physical examination and electrocardiogram. Subat each dose level with vein distension measurements jects with sensitivity to any of the pharmacological agents being made in the last 2 min. The same procedure was or related compounds were excluded from the study.
repeated on the other study day in the presence of a coinfusion of indomethacin (3 mg / min; Merck Frosst) through the distal needles of both hands. Previous studies have established that NE dose-response curves on different hands are similar and reproducible on different days [17] . The difference between baseline distension and that obtained at each dose level of NE was expressed as a percentage of the baseline distension (% venoconstriction).
A control study was performed in a normal subject to confirm that enalaprilat infusion in one hand would not affect responses to NE in the contralateral hand. In one hand, venoconstriction to cumulative doses of NE (1-1024 ng / min) was measured first in the presence of a saline infusion in the contralateral hand. After a suitable washout period, during which baseline vein distension was restored, the venoconstriction to the same doses of NE was mea- hand. In each of another two subjects, two needles were inserted into a dorsal hand vein in one hand and the veins were preconstricted by approximately 50% of baseline vein dent's t-test. Two-tailed P-values less than 0.05 were distension with PGF (Upjohn Company, Don Mills, ON, considered statistically significant. Canada; 256 ng / min in one subject and 512 ng / min in the other), given through the distal needle. The PGF infusion 2a was maintained for the rest of the study. After at least 15 3 . Results min equilibration, an infusion of enalaprilat (1000 ng / min) given through the proximal needle was started and main-3 .1. Subject characteristics tained for the rest of the study while vein distension was measured at similar intervals as before.
Baseline mean arterial pressures, heart rates and skin Skin temperature was continuously monitored in one temperatures were similar on the two study days (Table 1 ) hand by a temperature probe attached to a thermometer and did not change significantly with local norepinephrine with digital readout display (YSI 409B, VWR Scientific, infusions or over the duration of the studies. Baseline Mississauga, ON, Canada). Blood pressure and heart rate distension of the veins (Table 1) was not different between were measured throughout the study at 5 min intervals on the two hands and did not differ between the study days. the calf of the leg using an automated machine (Dinamap 846SX, Criticon, Tampa, FL, USA).
.2. Effects of indomethacin and enalaprilat on responses to NE

.3. Data analysis
In the control study, enalaprilat infusion in one hand for the same duration and at the same concentration as during Data are presented as the mean6S.E.M. where approthe actual studies did not affect responses to NE in the priate. Non-linear curve fitting analysis over the dose range contralateral hand (Fig. 1) . Neither enalaprilat nor infor infused NE was performed using a computer software domethacin affected baseline vein distension prior to program (Graphpad Inplot 4, H. J. Motulsky, San Diego, determination of NE dose-response curves. CA, USA). Comparisons of dose-response curves were Norepinephrine induced dose-dependent venoconstricmade using analysis of variance for repeated measures.
tion during the various treatments in all subjects (Fig. 2) . Comparisons of means were made using the paired StuEnalaprilat shifted the NE dose-response curve to the right Indo, indomethacin; S, saline; Enal, enalaprilat; Enal1Indo, enalaprilat1indomethacin. (P50.024), resulting in an increase in NE log ED (NE 50 dose causing 50% venoconstriction; 2.3160.11 vs. 1.7060.08 log ng / min with saline, P50.001; Fig. 3 ). Indomethacin shifted the NE dose-response curve to the left (P50.018) with a decrease in NE log ED 50 (1.0960.18 vs. 1.7060.08 log ng / min with saline, P5 0.002; Fig. 4 ). In the presence of indomethacin, enalaprilat caused a small but significant increase in the NE log ED 50 (1.2960.18 vs. 1.0960.18 log ng / min with indomethacin alone). The increase in NE log ED with enalaprilat was 50 significantly reduced by indomethacin (delta 10.6160.11 vs. 10.2060.08 log ng / min, P50.008, Fig. 5 ).
Enalaprilat (1000 ng / min) infusion for 45 min did not cause dilation of veins preconstricted with PGF . This study represents an in vivo direct mechanistic evaluation of ACE inhibitor dilation of NE-induced venoconstriction at the local vascular level in normal subjects. Since the purpose of the study was to evaluate the contribution of vasodilator prostaglandins, intravenous indomethacin was used to block cyclooxygenase production of prostaglandins. The small doses of NE used caused only localized dose-dependent venoconstriction and did not alter systemic blood pressure or heart rate. Enalaprilat infusion caused local dilation of NE-induced venoconstriction, as evidenced by the significant shift to the right of the NE dose-response curve, again without evidence of systemic effects. Our results are consistent with others which have demonstrated attenuation of sympathetic vasoconstriction during ACE inhibition [7, 11, 18, 19] although the contribution of prostaglandins was not assessed. With indomethacin, responsiveness to NE was increased during rilat was significantly less during indomethacin coinfusion, consistent with our hypothesis that vasodilator prostaIndomethacin, available for intravenous use in humans, glandins contribute significantly to ACE inhibitor attenuawas used to achieve local inhibition of cyclooxygenase as tion of NE-induced venoconstriction.
earlier studies found comparable effects of indomethacin The results in the present study have demonstrated the [20] and orally administered ASA [16] on sympatheticability of indomethacin to modulate the actions of both NE mediated venoconstriction. Although there have been and enalaprilat, suggesting a contributory role of vasodilatreports of non-specific effects of indomethacin [27,28], or prostaglandins in human veins in vivo. Control responthese were reported at concentrations much higher than siveness to NE in this study was increased by inthose used in this study. Indomethacin did not alter domethacin, confirming the importance of prostaglandins baseline vein distension, thereby ruling out any direct in modulating the NE-induced venoconstriction consistent venoconstrictor effects. This also suggests that any basal with earlier studies using ASA [16] or other adrenoceptor release of vasodilator prostaglandins is very small and does agonists [20] . Similarly, vasodilation with enalaprilat was not play a significant physiologic role. substantially reduced by indomethacin. Under the conOur current findings appear to implicate prostaglandins ditions of this study in healthy normals, this suggests most as the principal mediators of ACE-inhibitor-mediated of the vasodilation to enalaprilat was mediated through dilation in normal human veins constricted with NE. This prostaglandins, most likely due to accumulation of bradymay have clinical implications in patients with carkinin [21] . Besides their stimulatory effects on prostadiovascular disease who are on concurrent treatment with glandins, it has been suggested that ACE inhibitors may ASA and ACE inhibitors. Some studies have reported cause vasodilation by other 'non-prostaglandin' mechaadverse effects of the inhibition of prostaglandin synthesis nisms. These include reduced synthesis of angiotensin II on the beneficial hemodynamic effects of ACE inhibitors by a local vascular tissue renin-angiotensin system [22] in patients with coronary heart disease and heart failure and bradykinin stimulation of other endothelium-derived [29] [30] [31] [32] , but the findings have not been consistent [33-vasodilators such as nitric oxide [9] . There is no clear 35] . So far, available data suggest that the interaction evidence from our study that these mechanisms play an between ACE inhibitors and ASA may be clinically important role in ACE inhibitor modulation of sympathetic relevant only at higher (.300 mg daily) and not lower venoconstriction to NE. However, there has been a recent doses of ASA which are used for prevention of thrombosis suggestion of significant basal and stimulated nitric oxide [31, 35] . We used one intravenously infused dose of inactivity in the quantitatively important smaller veins and domethacin and the clinical implications of our findings venules [23] although the role of prostaglandins was not need to be validated in prospective studies in which the studied. Results of another study suggest that both prosta-ASA treatment is randomized and different doses of ASA glandins and nitric oxide modulate venular tone [24] , are given concomitantly with ACE inhibitors. thereby raising the likelihood that our results in larger hand Bradykinin B -receptors are constitutively expressed 2 veins may also apply to the smaller veins and venules. and regulate vascular function in normal animal physiThe dose of enalaprilat was chosen to achieve local ology [36] . Bradykinin mediation of some ACE inhibitor concentrations at the study site approximating systemic effects has been demonstrated in a number of in vivo and levels attainable clinically in vivo [25] , assuming a in vitro animal and human studies [8, 9, 36] . The contribuperipheral venous blood flow of approximately 1 ml / min tion of bradykinin to the observed responses with enalap- [26] . Enalaprilat infusion in one hand did not alter rilat was not directly determined in the current study. As responses to NE in the contralateral hand as demonstrated chronic ACE inhibition may induce renal and vascular in the control study, thereby ruling out any confounding B -receptors [36], the magnitude of the acute changes we 1 effects of enalaprilat on the control NE dose-response observed may not be identical to those seen during chronic curve with saline. Furthermore, enalaprilat did not alter therapy. The effects of ACE inhibition were evaluated in baseline vein distension during the 15 min equilibration healthy subjects and further studies are indicated in period, consistent with the veins being in a state of near to patients with cardiovascular disease where the endomaximal dilation [26] under the environmental temperature thelium, an important modulator of vascular tone and and relaxed, quiet conditions of the study.
source of prostaglandins, may be dysfunctional [37, 38] . In Contrary to its effects on NE-induced venoconstriction, heart failure, there is potential for expression of inflamenalaprilat did not dilate veins which were preconstricted mation-induced B -receptors which have also been shown 1 with PGF , consistent with a previous study [11] . The to cause vasodilation that may involve prostaglandins [36] . observation that the effects of indomethacin on NE log The interactions of endothelial dysfunction, upregulation ED were greater in the presence of enalaprilat suggests of B -receptors, and prostaglandins requires further study. 
